Why we (need to) believe in books.
Monthly Bestsellers
Fulfillment & Customization Options
The 2023 Porchlight Business Book Awards
Testimonials
Contact Customer Service
Products / Book
By Jeffrey D Sachs
Jeffrey D. Sachs is one of the world's most perceptive and original analysts of global development. In this major new work he presents a compelling and practical framework for how global citizens can use a holistic way forward to address the seemingly intractable worldwide problems of persistent extreme poverty, environmental degradation, and political-economic injustice: sustainable development.
By Anne Case, Angus Deaton
"This book documents the decline of white-working class lives over the last half-century and examines the social and economic forces that have slowly made these lives more difficult. Case and Deaton argue that market and political power in the United States have moved away from labor towards capital--as unions have weakened and politics have become more favorable to business, corporations have become more powerful. Consolidation in some American industries, healthcare especially, has brought an increase in monopoly power in some product markets so that it is possible for firms to raise prices above what they would be in a freely competitive market. This, the authors argue, is a major cause of wage stagnation among working-class Americans and has played a substantial role in the increase in deaths of despair. [The authors] offer a way forward, including ideas that, even in our current political situation, may be feasible and improve lives"--
By Harriet A Washington
"With a new preface on risk factors for Covid-19"--Cover.
By Sheldon Krimsky
A dramatic new way to explore controversial science: Socratic dialogues. These creative debates follow the nuances and complexities of stem cell research and emerging therapies for informed readers and newcomers alike.
By Daniel Navon
With every passing year, more and more people learn that they or their young or unborn child carries a genetic mutation. But what does this mean for the way we understand a person. Today, genetic mutations are being used to diagnose novel conditions like the XYY, Fragile X, NGLY1 mutation, and 22q11. 2 Deletion syndromes, carving out rich new categories of human disease and difference.
By Joshua D Mezrich
"Although When Death Becomes Life is about courage and innovation and dedication, it is foremost a book about hope. . . . This monumental and enthralling history of one of modern medicine's most rousing triumphs is a definitive testament to that hope, and to the brave physicians and patients whose sacrifices made it possible.
By Cassandra Leah Quave
The uplifting, adventure-filled memoir of one groundbreaking scientist's quest to develop new ways to fight illness and disease through the healing powers of plants. "A fascinating and deeply personal journey. " --Amy Stewart, author of Wicked Plants and The Drunken Botanist Traveling by canoe, ATV, mule, airboat, and on foot, Dr.
Current Drug Synthesis The latest entry in the widely read Drug Synthesis series In Current Drug Synthesis , accomplished medicinal chemist and researcher Dr. Jie Jack Li and 27 expert coauthors deliver an authoritative and comprehensive discussion of the medicinal chemistry of current drugs, as well as the cutting-edge science involved in their synthesis.
By Jeffrey S Barrett
"This book discusses how to conduct pharmaceutical research and the context for how the industry fits into global healthcare. Holistically, the well-qualified author helps readers and students of drug development appreciate the time and expense of the process. Specifically, the work identifies the emerging trends shaping the future of drug development, along with important related topics like generic drugs, data sharing, and collaboration. To aid in seamless reader comprehension, the book includes a glossary of terms and a self-assessment quiz for each chapter at the end. PowerPoint slides are also available as an online ancillary for adopting professors"--
"This two-volume book is organized into 26 chapters and serves as a resource for any scientists investigating GPCRs, be it in academia or industry. The first volume provides in-depth information about the molecular pharmacology of this important target class and presents up-to-date material on GPCR structures and structure based drug design. The second volume includes information on the role of GPCRs in disease and novel approaches for studying this receptor family. Together, the two volumes thoroughly overviews GPCRs in terms of their structure, pharmacology, function, and role in disease states; and provides information on novel approaches to measure GPCR activity"--
We have updated our privacy policy. Click here to read our full policy.